FierceBiotechFierceBiotechResearchFierceBiotechITFierceVaccinesFiercePharmaFiercePharmaManufacturing   FierceHealthcare
Syndicate content

Whitepapers

The Whitepapers library on FierceBiotech.com contains whitepapers, case studies and research briefs on issues affecting biotechnology, including research and development, marketing and regulation.

If you would like to submit a whitepaper to the library, please visit the following link: Contact our advertising team



SharePoint and Documentum for Life Sciences: Simplified Collaboration / Compliance without Compromise

Source: 
EMC
While regulatory compliance is essential, life sciences organizations also need to provide an easy-to-use authoring and collaboration environment for users. Learn how to combine the advantages of... Read more...

Plant and Asset Management in Life Sciences: Solutions to Mitigate Risk and Reduce Costs

Source: 
EMC
EMC and McLaren Software have worked together for over ten years to help customers streamline and ensure a compliant engineering documentation process. Download our webcast and learn more.... Read more...

Reducing Risk with the Right CRO Partner: Evaluating CROs with Confidence

Source: 
INC Research
It has been well documented that CROs can expedite the R&D process for drug developers. But how can sponsors objectively evaluate their CROs partners? This paper by INC Research will examine key... Read more...

eClinical Visions – Clinical Trial Management: Enabling Operational Efficiency

Source: 
Oracle
The critical need for greater operational efficiency in clinical drug development is paramount. This paper has contributions from industry experts detailing their overall views of the future of... Read more...

Deploying Adobe solutions to automate electronic submissions component creation

Source: 
Adobe
As a trusted enterprise partner, Adobe LiveCycle helps you streamline both paper-based and electronic elements of the submissions process including document creation, collaboration, assembly, review... Read more...

Personalized Medicine: Closer to Reality?

Source: 
Enterprise Florida
Author: 
John Carroll, FierceBiotech editor
Personalized medicine is considered to be the future of healthcare. Yet, little specific information is available on how it will affect drug developers, healthcare professionals and patients. Learn... Read more...

Thought Leader Training

Source: 
Cutting Edge Information
Author: 
Jordan Stone

With increased public and governmental concern, physicians' relationships with the pharmaceutical industry seem to receive ever-escalating scrutiny from both regulatory bodies and state legislators.

... Read more...

Outcomes-Based Pricing: Meeting Payer Demands

Source: 
Cutting Edge Information
Author: 
Haley Wynn, Research Analyst

The global pharmaceutical market is not what it used to be. Pharmaceutical and biotech companies face a number of pricing challenges that were practically nonexistent in the 1990s. Evidence-based

... Read more...

Webdevelopment best practices for biotech companies

Source: 
study by Pronovix
Author: 
Kristof Van Tomme, Wim Liekens
Building a website for your biotech company might seem a daunting task, especially the first time you do it. That is why we at Pronovix created this whitepaper: to give you an introduction into the... Read more...

Gifts to Physicians: Just a Simple Thank-You or a Corporate Risk?

Source: 
Watermark
Reports from the industry associations and varies journals state that approximately 94% of physicians had received food, drug samples, or other reimbursements and payments from industry. The question... Read more...

Demonstrating MSL Programs' ROI

Source: 
Cutting Edge Information - Consulting Division
Author: 
Yanis Saradjian

Cutting Edge Information recently completed several studies focusing on Medical Liaisons and Opinion Leader management. The results revealed a trend in how MSLs are taking an ever increasing role in

... Read more...

Making Biotechnology Work for New Zealand

Source: 
Victoria University of Wellington & Pukana Partners
Author: 
Mark Ahn, Michael Meeks, Christine Ross, Sophie Dalziel, Rebecca Bednarek

Biotechnology holds great promise for solving many of the world's looming challenges from energy and food shortages; to the diagnosis, treatment and prevention of intractable diseases; to

... Read more...

Risk Management + Post-Market Safety Strategies = Improved Financial Ratings

Source: 
Watermark
On March 1 Standard & Poor's implemented new credit rating rules around Enterprise Risk Management Analysis for Nonfinancial Companies. Read more...

Smartsourcing in Eastern Europe.

Source: 
Forbes (www.forbes.com), The New York Times (www.nytimes.com), Gartner (www.gartner.com)
Author: 
Viktor Bogdanov

In 2008 the outsourcing business of Eastern Europe was estimated at nearly $2 billion, representing just a tiny fraction of the global IT outsourcing market, estimated at about $386 billion.

... Read more...

"So You Have an Outcome Registry, Now What? Practical Tips to Registry Administration"

Source: 
Watermark
Robust risk management strategies include outcome registries used to collect safety, efficacy, clinical benefit, and QOL information. Independence of the data and regulatory scrutiny should be... Read more...